Pediatric Obesity Track

Obesity Conference Pediatric Obesity Track

Date: October 5
Accreditation: 6.5 CME/CE and 6.5 MOC points (ABP)
Level: Advanced
Time: 10:00 AM-5:30 PM

The Pediatric Track will be held during the Fall Obesity Summit and offers advanced pediatric-specific education for healthcare providers who have previous experience managing obesity in pediatric patients. The Pediatric Obesity Weight Evaluation Registry (POWER) will also present and participate in the Pediatric Track.

  • Learn best practices and advanced techniques for managing childhood obesity.
  • Understand the differences in evaluation, disease markers, and treatment tactics in pediatric patients vs. adults.
  • Discuss how childhood obesity affects pharmacokinetics and how to adjust medications accordingly.
  • Explore the impact of obesity on bone metabolism.
  • Discover how to manage dyslipidemia in pediatric patients.
  • Review common mental health conditions found in children with obesity and available screening tools.
  • Feel more comfortable discussing obesity treatment options with parents and children.
  • Hear about the POWER Group's pediatric obesity treatment and prevention outcomes.
  • Connect with other obesity medicine pediatricians and members of the POWER Group.


The Pediatric Track is part of the Fall Obesity Summit on Saturday, October 5.

10:00-10:45 AM - Drug Dosing for Children with Obesity: Outpatient Setting

Valentina Shakhonovich, MD

Despite rising obesity rates in children, little guidance exists regarding the dose selection of medications for this growing patient population. Total body weight-based dosing is not always the answer, but neither is adult dosing, as children are not small adults. Furthermore, obesity-related changes in organ physiology can impact drug pharmacokinetics, resulting in sub-therapeutic or supra-therapeutic drug levels and placing children at risk for treatment failure or drug toxicities. During this lecture, discuss the pharmacologic data available in children with obesity for some of the most commonly prescribed medications in the outpatient setting, and identify common themes and gaps in knowledge.

  • Review dose adjustment evidence for commonly prescribed drugs in pediatrics.
  • Discuss dose adjustments for drugs prescribed for obesity-related co-morbidities.
  • Discuss dose adjustments for drugs with narrow theraputic index.
  • Understand Scaling vs. Physiologically-Based Dosing Approaches.
  • Identify common themes, gaps in knowledge, and possible solutions.

10:45-11:30 AM - Obesity and Bone Metabolism in Adolescents

Madhusmita Misra, MD, MPH

Review the impact of obesity on bone metabolism in adolescents and young adults.

  • Explore the impact of obesity on bone density, microarchitecture, and strength estimates.
  • Define the marrow fat-bone connection in obesity.
  • Explore mechanisms underlying impaired bone metabolism in obesity.

11:30 AM-12:30 PM - Review of Pediatric Outcomes

Shelley Kirk, PhD, RD, LD

12:45-1:30 PM - Screening and Understanding Rare Genetic Variants Impacting Early-Onset, Severe Obesity (Working Lunch)

Wendy Chung, MD, PhD

Corporate support for this session is provided by Rhythm Pharmaceuticals.

Rare genetic disorders of obesity are ultra-rare diseases that result from genetic variants of the melanocortin-4 receptor (MC4R) pathway, which is a component of the central melanocortin pathway. Variants in genes comprising this pathway result in impaired MC4R pathway signaling and may lead to insatiable hunger hyperphagia, decreased energy expenditure, and increased body weight. Understanding the phenotypes as well as the underlying causes (e.g. genetic) of the different types of dysfunctional eating may help with clinical decision making. This program will focus on identifying individuals with genetic causes of obesity (such as rare genetic disorders of obesity) through genetic testing.

The presentation will provide a deeper understanding of when to initiative genetic testing in individuals with severe obesity and how to interpret/understand results from genetic screening tests. Because clinicians who see individuals with obesity may not be familiar with interpreting results from genetic tests, Dr. Chung will also be discussing how to navigate around the field of genetics and review rare genetic variants that can influence clinical characteristics of obesity.

12:30-1:45 PM - Lunch in Exhibit Hall

For those not attending the lunch session, lunch will also be served in the exhibit hall.

1:45-3:00 PM - Childhood Dyslipidemia: How to Use Labs in the Treatment of Obesity

William Stratbucker, MD, MS

  • Understand the factors involved in lab screening in pediatric patients with obesity.
  • Explore the current guidelines related to lab screening with attention to clinical significance.
  • Learn about lipid screening in childhood, including current recommendations, controversies, and management of dyslipidemias.

3:00-3:45 PM - Final Break in Exhibit Hall

This is the last opportunity to visit the exhibitors and explore the latest technologies, products, and services available for your practice. Snap a selfie at any of the sponsored selfie walls and post it to social media!

3:30 PM - Trail Map Prize Drawing

Make sure you're at the Exhibit Hall Stage for the trail map prize drawing. Two winners will be drawn at random, and each will win a $1,000 gift card!

3:45-4:45 PM - Mental Health in Pediatric Obesity: Tools for the Medical Practitioner

Melissa Santos, PhD

  • Learn about the prevelance of mental health conditions found in youth with obesity.
  • Review the variety of mental health conditions youth present to obesity clinics.
  • Explore two motivational interviewing tools to engage youth in care.
  • Discover two mental health screening tools that can be implemented into your practice.

4:45-5:30 PM - Pediatric Panel Discussion

Madhusmita Misra, MD, MPH; Melissa Santos, PhD; and Valentina Shakhonovich, MD

  • Discuss the consequences of obesity on the skeletal system in pediatric patients with obesity.
  • Apply common behavioral assessment tools in the evaluation of pediatric patients with obesity.
  • Clarify the impact of obesity on pharmacokinetics in the pediatric population.

5:30-6:30 PM - Mentorship Meetup

If you’re participating in the mentorship program at the conference, take this opportunity to meet with your mentor or mentee(s)!

6:45 PM - Dine-arounds

Need dinner plans? Sign up at the member center to attend a dine-around, and join a group of fellow attendees for dinner at a restaurant near the hotel.*

*Dinner costs are each individual’s responsibility.


To attend the Pediatric Track, you can register for either the Fall Obesity Summit (Oct. 4-6) or the Saturday One-Day Pass (Oct. 5).

Register Now


Successful completion of this CME activity, which includes participation in the activity and individual assessment of and feedback to the learner, enables the learner to earn up to 6.5 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting ABP MOC credit.


The Pediatric Obesity Weight Evaluation Registry (POWER) was established in 2013 and now includes 30 medical institutions in 21 states. The purpose of the POWER group is to identify and promote effective intervention strategies for pediatric obesity.